e-learning
resources
London 2016
Tuesday, 06.09.2016
Novel avenues in the treatment of COPD II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Direct cost analysis of COPD patients: A 1 year follow-up study
Suleyman Savas Hacievliyagil (Malatya, Turkey), Ünal Akel, Süleyman Savas Hacievliyagil, Zeynep Ayfer Aytemur, Saim Yologlu, Saltuk Bugra Kaya, Nazan Akel
Source:
International Congress 2016 – Novel avenues in the treatment of COPD II
Session:
Novel avenues in the treatment of COPD II
Session type:
Thematic Poster
Number:
4070
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Suleyman Savas Hacievliyagil (Malatya, Turkey), Ünal Akel, Süleyman Savas Hacievliyagil, Zeynep Ayfer Aytemur, Saim Yologlu, Saltuk Bugra Kaya, Nazan Akel. Direct cost analysis of COPD patients: A 1 year follow-up study. Eur Respir J 2016; 48: Suppl. 60, 4070
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Outcomes in patients with COPD during a 3 year follow-up
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Pharmacoeconomic evaluation of COPD: A 1 year follow-up study
Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription
Year: 2010
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Effect of non-invasive mechanical ventilation on exacerbations in patients with stable COPD: A 4 year cohort study with one year follow-up
Source: International Congress 2015 – Novelties in noninvasive ventilation
Year: 2015
Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017
The cost analysis of our COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006
Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Real-life COPD patients compared to large trial populations: An UNLOCK external validity study
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
Change of COPD maintenance medication over two years in a large real life cohort: The DACCORD study
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
An integrated disease management (IDM) programme of 12 months duration was effective for patients with COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
Source: International Congress 2018 – COPD management
Year: 2018
COPD management in general practice –One year follow-up of the Swiss COPD cohort study
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
The cost of COPD: results from the SIRIBO study
Source: Eur Respir J 2002; 20: Suppl. 38, 125s
Year: 2002
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept